QIC Holds a US$528 Million First Close on QIC Global Infrastructure Fund (Global)

QIC, a global diversified alternative investment firm, has announced that its QIC Global Infrastructure Fund has secured initial capital commitments totaling US$528 million from four institutional investors. The investors included an Asian sovereign wealth fund and an Australian pension scheme. The fund will seek infrastructure investment opportunities in markets around… Read More

IDFC Alternatives to Partially Exit Green Infra for INR10.6 Billion (Asia)

Singapore-based energy, water and marine group Sembcorp Industries has signed agreements to acquire a 60 percent stake in India-based renewable energy company Green Infra from India-focused private equity firm IDFC Alternatives for INR10.6 billion (approximately US$170 million). The transaction will be structured through IDFC Private Equity Fund II and IDFC… Read More

Cheyipai Raises US$110 Million in a Series D Financing Round (Asia)

China-based social networking platform Renren has led a US$110 million Series D financing round for China-based second-hand car trading platform Cheyipai. Venture capital firms Sequoia Capital, Matrix Partners and Morningside Technologies and CITIC Capital, the private equity arm of CITIC Capital Holdings, also participated in the round. The company intends… Read More

The Carlyle Group Receives Approval to Buy Destimoney’s Indian Arm (Asia)

The Competition Commission of India has approved Mauritius-based financial services company Destimoney Enterprises’ proposed sale of its Indian arm to Quality Investment Holdings, an entity controlled by alternative asset manager The Carlyle Group, for a reported US$200 million. Carlyle will acquire a 100 percent stake in Destimoney Enterprises’ Indian arm. Read More

InvAscent’s India Life Sciences Fund II Invests Across Two Medical Device Companies (Asia)

India-focused private equity firm InvAscent has invested INR920 million (approximately US$15 million) across two India-based medical device companies: Comprehensive Prosthetics and Orthotics (CPO), a manufacturer of artificial limbs, and Relisys, a manufacturer of medical devices that treat life-threatening diseases. The transactions were structured through India Life Sciences Fund II. InvAscent… Read More



(default archive template)